$16.73
0.321.95%
At Close: -
$16.73
00.00%
After Hours: 1:00 PM EDT
15 minutes delayed
Healthcare Realty Trust
HRNYSE
Healthcare Realty Trust (NYSE:HR) Stock, Analyst Ratings, Price Targets, Predictions
Healthcare Realty Trust Inc has a consensus price target of $19.57, established from looking at the 33 latest analyst ratings. The last 3 analyst ratings were released from Wells Fargo, Wells Fargo, and Scotiabank on June 14, 2024, May 30, 2024, and May 16, 2024. With an average price target of $16.33 between Wells Fargo, Wells Fargo, and Scotiabank, there's an implied -2.37% downside for Healthcare Realty Trust Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
Wells Fargo
Scotiabank
Wedbush
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Healthcare Realty Trust
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/14/2024 | Buy Now | 1.61% | Wells Fargo | Joseph Feldman | $16 → $17 | Maintains | Equal-Weight | Get Alert |
| 05/30/2024 | Buy Now | -4.36% | Wells Fargo | James Feldman | $15 → $16 | Maintains | Equal-Weight | Get Alert |
| 05/16/2024 | Buy Now | -4.36% | Scotiabank | Nicholas Yulico | $15 → $16 | Maintains | Sector Perform | Get Alert |
| 05/08/2024 | Buy Now | -4.36% | Wedbush | Richard Anderson | $15 → $16 | Maintains | Neutral | Get Alert |
| 04/10/2024 | Buy Now | -10.34% | Wells Fargo | Connor Siversky | $18 → $15 | Maintains | Equal-Weight | Get Alert |
| 03/06/2024 | Buy Now | 1.61% | JP Morgan | Michael Mueller | $19 → $17 | Maintains | Overweight | Get Alert |
| 02/20/2024 | Buy Now | -10.34% | Wedbush | Richard Anderson | $19 → $15 | Downgrade | Outperform → Neutral | Get Alert |
| 02/20/2024 | Buy Now | -10.34% | Stifel | Stephen Manaker | $19 → $15 | Downgrade | Buy → Hold | Get Alert |
| 01/30/2024 | Buy Now | 7.59% | Deutsche Bank | Omotayo Okusanya | → $18 | Initiates | → Hold | Get Alert |
| 11/13/2023 | Buy Now | -4.36% | Wells Fargo | Connor Siversky | $17 → $16 | Maintains | Equal-Weight | Get Alert |
| 11/06/2023 | Buy Now | 1.61% | Wedbush | Richard Anderson | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 10/24/2023 | Buy Now | 1.61% | BTIG | Michael Gorman | → $17 | Upgrade | Neutral → Buy | Get Alert |
| 10/12/2023 | Buy Now | 13.57% | JP Morgan | Michael Mueller | → $19 | Upgrade | Neutral → Overweight | Get Alert |
| 10/10/2023 | Buy Now | 1.61% | Scotiabank | Nicholas Yulico | $19 → $17 | Maintains | Sector Perform | Get Alert |
| 10/06/2023 | Buy Now | 1.61% | BMO Capital | Juan Sanabria | $20 → $17 | Maintains | Market Perform | Get Alert |
| 10/03/2023 | Buy Now | 1.61% | Wedbush | Richard Anderson | → $17 | Initiates | → Outperform | Get Alert |
| 08/22/2023 | Buy Now | 1.61% | Citigroup | Michael Griffin | $19 → $17 | Maintains | Neutral | Get Alert |
| 08/11/2023 | Buy Now | 43.45% | Barclays | Steve Valiquette | $25 → $24 | Maintains | Equal-Weight | Get Alert |
| 05/11/2023 | Buy Now | 49.43% | Barclays | Steve Valiquette | $24 → $25 | Maintains | Overweight | Get Alert |
| 04/19/2023 | Buy Now | — | Wells Fargo | Connor Siversky | — | Initiates | → Equal-Weight | Get Alert |
| 03/29/2023 | Buy Now | 43.45% | Barclays | Steve Valiquette | $28 → $24 | Maintains | Overweight | Get Alert |
| 03/06/2023 | Buy Now | 19.55% | Credit Suisse | Omotayo Okusanya | $23 → $20 | Downgrade | Outperform → Neutral | Get Alert |
| 12/14/2022 | Buy Now | 19.55% | Citigroup | Michael Griffin | $22.5 → $20 | Downgrade | Buy → Neutral | Get Alert |
| 12/02/2022 | Buy Now | 31.5% | JP Morgan | Michael Mueller | $28 → $22 | Maintains | Neutral | Get Alert |
| 09/19/2022 | Buy Now | 67.36% | Citigroup | Michael Bilerman | $27 → $28 | Upgrade | Neutral → Buy | Get Alert |
| 08/11/2022 | Buy Now | 79.32% | SMBC Nikko | Richard Anderson | → $30 | Upgrade | Neutral → Outperform | Get Alert |
| 07/18/2022 | Buy Now | 73.34% | Credit Suisse | Sam Choe | $34 → $29 | Maintains | Outperform | Get Alert |
| 05/10/2022 | Buy Now | 91.27% | Berenberg | Conor Siversky | $35 → $32 | Downgrade | Buy → Hold | Get Alert |
| 04/26/2022 | Buy Now | 97.25% | Barclays | Steve Valiquette | → $33 | Initiates | → Overweight | Get Alert |
| 02/01/2022 | Buy Now | — | Credit Suisse | Tayo Okusanya | — | Initiates | → Outperform | Get Alert |
| 01/07/2022 | Buy Now | 103.23% | BMO Capital | John Kim | → $34 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/20/2021 | Buy Now | — | Raymond James | Jonathan Hughes | — | Downgrade | Strong Buy → Market Perform | Get Alert |
| 07/29/2021 | Buy Now | 97.25% | Morgan Stanley | Vikram Malhotra | — | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Healthcare Realty Trust (HR) stock?
The latest price target for Healthcare Realty Trust (NYSE:HR) was reported by Wells Fargo on June 14, 2024. The analyst firm set a price target for $17.00 expecting HR to rise to within 12 months (a possible 1.61% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Healthcare Realty Trust (HR)?
The latest analyst rating for Healthcare Realty Trust (NYSE:HR) was provided by Wells Fargo, and Healthcare Realty Trust maintained their equal-weight rating.
When was the last upgrade for Healthcare Realty Trust (HR)?
The last upgrade for Healthcare Realty Trust Inc happened on October 24, 2023 when BTIG raised their price target to $17. BTIG previously had a neutral for Healthcare Realty Trust Inc.
When was the last downgrade for Healthcare Realty Trust (HR)?
The last downgrade for Healthcare Realty Trust Inc happened on February 20, 2024 when Wedbush changed their price target from $19 to $15 for Healthcare Realty Trust Inc.
When is the next analyst rating going to be posted or updated for Healthcare Realty Trust (HR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Realty Trust, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Realty Trust was filed on June 14, 2024 so you should expect the next rating to be made available sometime around June 14, 2025.
Is the Analyst Rating Healthcare Realty Trust (HR) correct?
While ratings are subjective and will change, the latest Healthcare Realty Trust (HR) rating was a maintained with a price target of $16.00 to $17.00. The current price Healthcare Realty Trust (HR) is trading at is $16.73, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.